The FDA OKs Pfizer-BioNTech Booster For People 65+ And At High Risk For Severe COVID
A third shot of the vaccine can be given at least six months after the two-dose regimen, according to the authorization. A booster rollout could begin this week.
Read more on NPR
Wednesday, 22 September 2021
The FDA OKs Pfizer-BioNTech Booster For People 65+ And At High Risk For Severe COVID
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Nothing happens without a Reason
Make Something out of it.